Swiss Rockets is dedicated to developing groundbreaking medicines that transform the treatment of cancer, infectious diseases, and autoimmune disorders – advancing more effective, equitable, and accessible healthcare for patients worldwide.

Mirava Bio is a Swiss BioCommercial Partner enabling emerging biotechs to bring rare disease & gene therapies to Europe, the Middle East & Eurasia. We define optimal go-to-market strategies and execute via a plug-and-play licensed ready platform, minimizing risk while partners retain control.

Topadur Pharma AG, founded in 2015 in Schlieren, is a clinical-stage biopharmaceutical company. Leveraging its proprietary DualTOP™ platform, Topadur develops dual-acting molecules that restore cGMP levels, repairing microcirculation, promoting tissue regeneration, and addressing oxygen deficiency.

Baker McKenzie is an international law firm with offices in Geneva and Zurich, offering top-tier legal advice across all areas of business law. Our team of 130 lawyers provides domestic and international clients with innovative solutions across 74 offices in 45 countries.

Life Science Cares Switzerland uses the innovation, financial and human resources of the life science industry to support local charitable projects. Main focus is promoting educational equity by providing young people from socially disadvantaged backgrounds with opportunities in our industry.

The grow Foundation provides small and large Life Sciences companies ready-to-use laboratories, offices, piloting and production facilities in Wädenswil/Horgen, in size ranging from a few working benches to several thousand m2.

Enzene is a fully integrated CIDMO with sites in Pune (India) & New Jersey (USA), offering discovery to commercial supply. Its EnzeneX™ FCCM™ tech leads next-gen biologics, aiming to cut mAb costs below $40/g by 2025. Learn more at www.enzene.com.

Xcube.bio invests capital, knowledge and capabilities in the European market entry of late-stage biopharmas, with the objective to create partners' own commercial footprint and revenue streams. We offer a unique value proposition that open and de-risk the European market for innovative therapies.

Chelonia collaborates with industry, academia, and public institutions to accelerate R&D, commercialize innovations, and secure funding. We offer strategic partnerships, expert guidance, and project support to maximize impact.

ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers on utilizing the alpha-emitting isotope Pb212 to target cancer cells while minimizing damage to healthy tissues.

FatiAbGen International is the Swiss subsidiary of FatiAbGen Co. Ltd., established in Korea in 2020. We engineer best in class antibodies tailored for multiple modalities such as ADCs and bi-specifics. We then develop targeted molecules to address high unmet need diseases in oncology and immunology.

PULSE is the latest state-of-the-art life sciences innovation center located in the heart of the Swiss health valley in Cheseaux-sur-Lausanne. Spanning an area of 43,000m², PULSE serves as a hub for cutting-edge companies in the life sciences industry.

We are managing a portfolio of biotech opportunities, each selected based on promising science and potential for addressing unmet medical needs. Our team of industry-leading experts has extensive development & biotech experience which we put into practice to accelerate science into care.

Curie.Bio is a $1.2B VC founded to discover and develop important new medicines. We do that by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. Our team of >80 full-time drug hunters provides hands on support to founders.

B Squared helps biotech and cell & gene therapy companies navigate complex CMC, manufacturing, and sourcing challenges. We bring hands-on expertise, real-world solutions, and a no-nonsense approach to getting things done. www.bsquared.ch

Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.

We at INCAPTEK are developing advanced drug delivery systems. We deliver drugs at the right place, in the right dosage, and at the right time. Our smart, programmed-shell micro(nano)capsules can be used for controlled and targeted drug delivery for both biotech and medtech.

IPS-Integrated Project Services, a Berkshire Hathaway company, is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, procurement, construction management, and CQV of technically complex facilities in the life sciences industry.

Toxicology Consultant with >25 years of experience in the Biopharmaceutical Industry. I support Startup and Biotech Companies to advance their projects into the clinical phase. Get in touch to discuss your project when you have a shortage of nonclinical and toxicological expertise.

Volv Global is a healthcare intelligence company using advanced, privacy-first AI to uncover undiagnosed patients, enable earlier detection, and predict outcomes. We deliver precise, population-scale insights that help innovators transform care and improve patient futures worldwide.

EvlaBio is a life science startup dedicated to the development of first-in-class therapeutics in the cardiovascular and cardiorenal space. The lead asset is a Therapeutic Monoclonal Antibody (mAb) targeting unphysiological FGFR4/FGF23 cardiac overdrive in the setting of chronic kidney disease (CKD).

Azafaros is a clinical-stage biotech addressing rare genetic lysosomal storage disorders with oral small molecules, including nizubaglustat. Our focus is on developing disease-modifying therapies for patients with GM1 and GM2 gangliosidoses, and Niemann-Pick Disease Type C.

Pheida develops and deploys biotech solutions at scale to reduce GHG emissions and other pollutants, and to remediate contaminated soil and water. Pheida products combine advanced biotech, proprietary application engineering to deliver unique and commercially attractive solutions.

BigOmics is a Swiss biodata analytics startup developing platforms for biologists to easily visualize and understand their omics data. Our aim is to fast-track data analysis processes in Life Science and significantly reduce discovery time and R&D overhead costs.

Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments.

House of Lab Science is the ultimate destination for serviced laboratory space across Switzerland. We believe that lab space should be ready-to-move in, affordable, certified & well equipped. Our lab-as-a-service model is designed to help you advance your research and business from day one.

CROss Alliance® is a Swiss CRO specialised in early clinical development. With more than 500 trials performed at CROSS phase I unit or in selected EU sites, we are experts in PK, bioequivalence, first in man, tolerability studies including cardiac safety and efficacy models in healthy volunteers.

PolyPeptide Group is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.

Santersus AG is an innovative Therapeutic Apheresis company focused on using our patented technology for the cleansing of patient blood of cell free DNA and neutrophil extracellular traps (NETs) looking to revolutionize how we can control the human immune and inflammatory response to disease.

Zambon Biotech is part of the Zambon group, it is focused in growing the portfolio and pipeline of the Zambon group by entering into partnerships, acquiring assets and supporting their clinical development up to commercialization as well as licensing commercial stage assets.

Founded in 2012, headcount is a Swiss recruitment agency specializing in Biotech, Medtech, Pharma, and Digital Health. We combine scientific expertise with recruitment excellence to connect top talent with leading companies, ensuring a perfect cultural and professional fit.

Pharma-Consulting ENABLE GmbH provides support to biopharmaceutical companies (small & large) in product development and manufacturing covering early to late stage clinical and commercial operations. Pharma-Consulting ENABLE is active worldwide and has been created by Alain Pralong in 2008.

Holding, management consulting & strategy advisory focused on biotech, medtech, nutraceuticals and health services. Our strong knowledge of international competitive and synergistic landscape and our large network of strategic partners help our clients to expand into new jurisdictions and markets.

SENN is a real estate company and as such is developing the GRID in Allschwil. A biotech ecosystem of 40'000m2 leasable space around the anchors Switzerland Innovation Park Basel and the University of Basel. Take your company here: www.gridbasel.ch, Hegenheimermattweg 150, 4123 Allschwil, Switzerland.

Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.

TargImmune Therapeutics AG is a private Swiss-based biotechnology company focused on drug development using novel targeted onco-immunotherapies.

valuationLAB AG is an independent life science research boutique. Our aim is to unlock value by translating complicated science into easy-to-understand financial forecasts and valuations, and sharing this with investors.

Venture Valuation specializes in independent assessments and valuations of companies/products in biotech/life sciences and runs the business development database Biotechgate with global licensing deals and opportunities www.biotechgate.com and Biotechgate Digital Partnering www.digitalpartnering.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

tiventa takes care for fresh air! Our mission is to clean the ventilation system in all kind of buildings, restaurants, industries, apartments and more. We are protecting people from airborne contaminants from entering room air and to maintain healthy indoor air quality.

Switzerland Global Enterprise (S-GE) links companies, experts and public organisations globally, thus facilitating efficient promotion of foreign trade. Apart from export promotion, S-GE is responsible for promoting Switzerland as a business location abroad.

QuartzBio SA is a Swiss data driven biomarker discovery and validation company and the trusted partner of companies and institutions for their in-silico biomarker discovery programmes. Leveraging a unique Biomarker Optimisation Software System – BOSS™ – we discover and validate biomarkers.

SAKK is a non-profit organization since 1965 investigating the efficacy and tolerability of new cancer therapies and further develops existing tumor treatments in adults. Our objective is to apply the best possible treatment. We see ourselves as the Swiss competency center for oncology trials.

PeptART manufactures a large variety of amino acid derivatives, pseudoprolines, and peptides on-site in our facility in Switzerland. We deliver our products from a few grams up to several tens of kg worldwide. Trust builds on quality and expertise - PeptART - Your Swiss pARTner in Peptide Chemistry.

As an independent pharma consulting company, we have supported pharma and biotech companies since 2007. With a team of more than 25 consultants, Qualified Persons and support staff, three offices and hundreds of pharma partners in over 30 countries worldwide, we are ready to solve your challenges.

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Novimmune SA has brought 7 monoclonal antibodies to clinical development stage, one of which, Emapalumab, has been approved by the FDA in 2018. We now focus on our bispecific technology to build a pipeline of multispecific antibodies under the brand Light Chain Bioscience.

Microsphere (MS) is a CDMO focused on new developments, cGMP manufacturing, R&D, analytical and regulatory support. MS is able to address complex challenges, including formulations for poorly water-soluble drugs, considering the extensive expertise in Spray Drying and Capsule Filling.

InterAx developed a unique drug discovery platform integrating biochemistry, cellular pathways mathematical modelling and AI to decode the cellular communication language. This novel approach enables the rapid and precise identification of differentiated effective and safe candidates.

InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding healthy and diseased human physiology in vitro.

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology and dermato-oncology.

HGF GmbH is one of Europe’s largest firms of IP specialists. With a dynamic and forward-thinking growth strategy, the firm is one of the few to offer clients a fully integrated IP solution, with 25 offices throughout the UK, Ireland, the Netherlands, Germany, Switzerland, France, and Austria.

Calliditas is a commercial stage biopharmaceutical company focused on novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. In 2021, Calliditas acquired Genkyotex, specializing company in NOX therapies, French & Swiss based.

Future Health Pharma GmbH represents companies adhering to the highest ethical principles and having irreproachable research and manufacturing records, registers, distributes and markets their products in Switzerland.

We are a Swiss company promoting innovation and technology using our comprehensive and highly qualified expert knowledge. We offer company assessments and consulting and management to support all actors involved in “turning scientific innovation into successful products on the market”.

evitria specializes in CHO-based transient expression of recombinant proteins, with a focus on antibodies—including bispecific, Fc-silenced, and afucosylated formats. With over 100,000 transfections, we are a trusted partner for biotech and pharma worldwide.

EffRx Pharmaceuticals SA is a commercial-stage pharmaceutical company, based in Switzerland, that develops and commercializes prescription medications for specialty indications. The primary focus is on therapeutics for men and women with musculoskeletal, genitourinary and rare diseases. Abiogen Pharma acquire

Curatis acquires, licences, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and speciality diseases in Switzerland. We have a promising pipeline of novel speciality care and orphan drugs for neurological disorders

CRB is a leading design, construction and consulting firm serving life sciences companies globally since 1984. From small studies to execution of complex projects, we have the expertise to deliver solutions to our clients in the local pharmaceutical and biotechnology market.

We at Bioengineering AG design and build customized equipment to improve bioproduction efficiency in biotech, novel food, and biopharma plants. Our engineering teams develop reliable bioreactors and fermenters, from lab scale to production, for clients worldwide. Trusted for over 50 years.

At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.